These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 36729438)
1. Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma. Geurts YM; Shakir R; Ntentas G; Roberti S; Aznar MC; John KM; Ramroth J; Janus CPM; Krol ADG; Roesink JM; van der Maazen RWM; Zijlstra JM; Darby SC; Aleman BMP; van Leeuwen FE; Cutter DJ; Schaapveld M JAMA Oncol; 2023 Apr; 9(4):481-489. PubMed ID: 36729438 [TBL] [Abstract][Full Text] [Related]
2. Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. van Eggermond AM; Schaapveld M; Janus CP; de Boer JP; Krol AD; Zijlstra JM; van der Maazen RW; Kremer LC; van Leerdam ME; Louwman MW; Visser O; De Bruin ML; Aleman BM; van Leeuwen FE Br J Cancer; 2017 Jul; 117(3):306-314. PubMed ID: 28632726 [TBL] [Abstract][Full Text] [Related]
3. Stomach cancer risk after treatment for hodgkin lymphoma. Morton LM; Dores GM; Curtis RE; Lynch CF; Stovall M; Hall P; Gilbert ES; Hodgson DC; Storm HH; Johannesen TB; Smith SA; Weathers RE; Andersson M; Fossa SD; Hauptmann M; Holowaty EJ; Joensuu H; Kaijser M; Kleinerman RA; Langmark F; Pukkala E; Vaalavirta L; van den Belt-Dusebout AW; Fraumeni JF; Travis LB; Aleman BM; van Leeuwen FE J Clin Oncol; 2013 Sep; 31(27):3369-77. PubMed ID: 23980092 [TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure. Krul IM; Opstal-van Winden AWJ; Aleman BMP; Janus CPM; van Eggermond AM; De Bruin ML; Hauptmann M; Krol ADG; Schaapveld M; Broeks A; Kooijman KR; Fase S; Lybeert ML; Zijlstra JM; van der Maazen RWM; Kesminiene A; Diallo I; de Vathaire F; Russell NS; van Leeuwen FE Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):843-853. PubMed ID: 28888722 [TBL] [Abstract][Full Text] [Related]
5. High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors. Rigter LS; Spaander MCW; Aleman BMP; Bisseling TM; Moons LM; Cats A; Lugtenburg PJ; Janus CPM; Petersen EJ; Roesink JM; van der Maazen RWM; Snaebjornsson P; Kuipers EJ; Bruno MJ; Dekker E; Meijer GA; de Boer JP; van Leeuwen FE; van Leerdam ME Cancer; 2019 Mar; 125(6):990-999. PubMed ID: 30561773 [TBL] [Abstract][Full Text] [Related]
6. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732 [TBL] [Abstract][Full Text] [Related]
7. Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma. van Nimwegen FA; Schaapveld M; Cutter DJ; Janus CP; Krol AD; Hauptmann M; Kooijman K; Roesink J; van der Maazen R; Darby SC; Aleman BM; van Leeuwen FE J Clin Oncol; 2016 Jan; 34(3):235-43. PubMed ID: 26573075 [TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design. Rigter LS; Spaander MC; Moons LM; Bisseling TM; Aleman BM; de Boer JP; Lugtenburg PJ; Janus CP; Petersen EJ; Roesink JM; Raemaekers JM; van der Maazen RW; Cats A; Bleiker EM; Snaebjornsson P; Carvalho B; Lansdorp-Vogelaar I; Jóźwiak K; Te Riele H; Meijer GA; van Leeuwen FE; van Leerdam ME BMC Cancer; 2017 Feb; 17(1):112. PubMed ID: 28173773 [TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy. Ykema BLM; Gini A; Rigter LS; Spaander MCW; Moons LMG; Bisseling TM; de Boer JP; Verbeek WHM; Lugtenburg PJ; Janus CPM; Petersen EJ; Roesink JM; van der Maazen RWM; ; Aleman BMP; Meijer GA; van Leeuwen FE; Snaebjornsson P; Carvalho B; van Leerdam ME; Lansdorp-Vogelaar I Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2157-2168. PubMed ID: 36166472 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer risk after treatment of Hodgkin lymphoma. Dores GM; Curtis RE; van Leeuwen FE; Stovall M; Hall P; Lynch CF; Smith SA; Weathers RE; Storm HH; Hodgson DC; Kleinerman RA; Joensuu H; Johannesen TB; Andersson M; Holowaty EJ; Kaijser M; Pukkala E; Vaalavirta L; Fossa SD; Langmark F; Travis LB; Fraumeni JF; Aleman BM; Morton LM; Gilbert ES Ann Oncol; 2014 Oct; 25(10):2073-2079. PubMed ID: 25185241 [TBL] [Abstract][Full Text] [Related]
12. Pooled Analysis of Meningioma Risk Following Treatment for Childhood Cancer. Withrow DR; Anderson H; Armstrong GT; Hawkins M; Journy N; Neglia JP; de Vathaire F; Tucker MA; Inskip PD; Brenner AV; Stovall MA; Diallo I; Berrington de Gonzalez A; Veiga LHS JAMA Oncol; 2022 Dec; 8(12):1756-1764. PubMed ID: 36201196 [TBL] [Abstract][Full Text] [Related]
13. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692 [TBL] [Abstract][Full Text] [Related]
14. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. Travis LB; Hill DA; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Wiklund T; Lynch CF; Van't Veer MB; Glimelius I; Storm H; Pukkala E; Stovall M; Curtis R; Boice JD; Gilbert E JAMA; 2003 Jul; 290(4):465-75. PubMed ID: 12876089 [TBL] [Abstract][Full Text] [Related]
15. Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children. Lo AC; Liu A; Liu Q; Yasui Y; Castellino SM; Kelly KM; Hererra AF; Friedberg JW; Friedman DL; Schwartz CL; Pei Q; Kessel S; Bergeron-Gravel S; Dama H; Roberts K; Constine LS; Hodgson DC JAMA Netw Open; 2024 Jan; 7(1):e2351062. PubMed ID: 38241048 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort. Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263 [TBL] [Abstract][Full Text] [Related]
17. Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma. Conway JL; Connors JM; Tyldesley S; Savage KJ; Campbell BA; Zheng YY; Hamm J; Pickles T Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):35-41. PubMed ID: 27979454 [TBL] [Abstract][Full Text] [Related]
18. Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma. Almagro-Casado E; Sánchez A; Cantos B; Salas C; Pérez-Callejo D; Provencio M Clin Transl Oncol; 2016 Jan; 18(1):99-106. PubMed ID: 26530956 [TBL] [Abstract][Full Text] [Related]
19. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. van Leeuwen FE; Klokman WJ; Stovall M; Hagenbeek A; van den Belt-Dusebout AW; Noyon R; Boice JD; Burgers JM; Somers R J Natl Cancer Inst; 1995 Oct; 87(20):1530-7. PubMed ID: 7563187 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors. Ykema BLM; Rigter LS; Spaander MCW; Moons LMG; Bisseling TM; Aleman BMP; Dekker E; Verbeek WHM; Kuipers EJ; de Boer JP; Lugtenburg PJ; Janus CPM; Petersen EJ; Roesink JM; van der Maazen RWM; Meijer GA; Schaapveld M; van Leeuwen FE; Carvalho B; Snaebjornsson P; van Leerdam ME Dig Endosc; 2022 Jan; 34(1):163-170. PubMed ID: 33928678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]